BioSpace.com News

Alkermes plc Reports Financial Results for Fiscal Year 2013 and Provides Financial Expectations

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Alkermes plc (NASDAQ: ALKS) today reported financial results for its fourth quarter and fiscal year ended March 31, 2013. The company also announced that it has changed its fiscal year-end from March 31 to Dec...

Phytopharm PLC Interim Results for the Six Months Ended 31 March 2013

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

23 May 2013 -- Phytopharm plc (PYM: London Stock Exchange) (Phytopharm or the Company or the Group) today announces its unaudited interim results for the six months ended 31 March 2013.

On the...

Concord Medical Services Holdings Limited Reports First Quarter 2013 Financial Results

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEIJING, May 21, 2013 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") CCM, a leading specialty hospital management solution provider and operator of the largest...

Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January ??? March 2013

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Moberg Pharma AB (publ) (STO:MOB)

Continued Strong Growth - Moberg Derma Becomes Moberg Pharma

FIRST QUARTER (JAN-MAR 2013)

Revenue MSEK 38...

Patheon Inc. Announces Date of Fiscal 2013 Second Quarter Financial Results

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORONTO, May 20, 2013 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading...

Alkermes plc to Host Conference Call to Discuss Financial Results for Fiscal Year 2013

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:00 a.m. EDT (1:00 p.m. BST) on Thursday, May 23, 2013, to discuss the companys financial results for its fiscal year ended March 31, 2013. Management...

PuriCore Interim Management Statement

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 17, 2013 -- PuriCore (LSE: PURI), the water-based clean technology company, today announces its Interim Management Statement for the period from 1 January 2013 to 17 May 2013 (which incorporates information...

Sinovac Biotech Ltd. to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEIJING, May 17, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of vaccines in...

AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) and Astellas Pharma Inc. Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced that additional data from the Phase 3 TIVO-1 trial (TIvozanib Versus sOrafenib in 1st line advanced RCC) of investigational agent...

Biostar Pharmaceuticals, Inc. Announces First Quarter 2013 Financial Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

XIANYANG, China, May 16, 2013

XIANYANG, China, May 16, 2013 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical...

Source BioScience Interim Management Statement

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

16 May 2013 -- Source BioScience plc (LSE: SBS), the international diagnostic and genetic analysis services business, today publishes its Interim Management Statement for the year to date.

Unless otherwise...

Veloxis Pharmaceuticals A/S Announces Financial Results for the First Three Months of 2013

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HORSHOLM, Denmark, May 15, 2013 /PRNewswire/ --

Highlights:

On 29 April, 2013 Veloxis submitted the MAA to the European Medicines Agency (EMA) seeking approval to market LCP-Tacro for...

Algeta Results for the First Quarter 2013

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

OSLO, NORWAY--(Marketwired - May 15, 2013) - Intended for US Media only

Algeta ASA (OSE: ALGETA), a company focused on the development of noveltargeted cancer therapeutics...

Beximco Pharmaceuticals' Financial Results for the First Quarter of 2013

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

15th May, 2013 -- Beximco Pharmaceuticals Limited (Beximco Pharma, "BPL" or "the Company"; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients...

China Pharma Holdings, Inc. Reports First Quarter 2013 Financial Results

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAIKOU CITY, China, May 15, 2013 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma" or the "Company"), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceutical...

DiaGenic ASA: Report From First Quarter 2013

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

The interim report for the first quarter 2013 was approved by the Board of Directors on 14 May 2013. Please find the interim report and presentation attached. Highlights from the...

Nanobiotix' Revenue for the 1st Quarter of 2013

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Paris, France, May 15, 2013 NANOBIOTIX (Euronext: NANO ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, today announces its revenue...

Prothena Reports First Quarter Financial Results

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, Ireland, May 14, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc. (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the potential...

Tianyin Pharmaceutical Co, Inc. Reports Third Quarter Fiscal Year 2013 Financial Results

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CHENGDU, China, May 14, 2013 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine...

WuXi PharmaTech Co., Ltd. Reports Higher Q1; Analyzes Prospects for Its Business

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

May 14, 2013 -- WuXi PharmaTech released positive financial results for the first quarter of 2013, as revenues increased 11.7% to $132 million. All sectors of the...

Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2013 First Quarter Earnings Conference Call on Thursday, May 16, 2013 at 9:00 a.m. ET

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

XIANYANG, China, May 14, 2013 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or...

Beximco Pharmaceuticals: Results for the Year Ended 31 December 2012

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 14, 2013 -- Beximco Pharmaceuticals Limited (Beximco Pharma, "BPL" or "the Company"; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients...

Evotec AG Q1 2013: Driving Innovation Efficiency

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAMBURG, Germany, May 14, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today reported financial results and corporate updates for the first quarter of 2013.

Help...

e-Therapeutics plc Preliminary Results for the Year Ended 31 January 2013

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

14 May 2013 e-Therapeutics plc (e-Therapeutics; AIM: ETX), the drug discovery and development company, today announces its preliminary results for the year ended 31 January 2013.

Highlights of...

GW Pharmaceuticals to Report Interim 2013 Results and Host Conference Call on June 3, 2013

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LONDON, May 14, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on...

Gentium S.p.A. Reports First Quarter Financial Results

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VILLA GUARDIA (COMO), Italy, May 14, 2013 (GLOBE NEWSWIRE) --Gentium S.p.A. (Nasdaq:GENT) (the "Company") today reported financial results for the quarter ended March 31, 2013. The Company reports its financial...

Suven Life Sciences Ltd's PAT Up by 115% for the Year Ended Mar 2013

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HYDERABAD, INDIA (14 May 2013) SUVEN LIFE Sciences Limited, a biopharmaceutical company specializing in drug discovery and developmental activities in Central Nervous System disorders, today announced its...

WuXi PharmaTech Co., Ltd. Announces First-Quarter 2013 Results

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United...

PuriCore Board Changes

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 14, 2013 -- PuriCore (LSE: PURI), the water-based, clean technology company, today announces changes to the Board. Charles Spicer, a seasoned medical technology executive based in the UK, has been appointed...

Amarin Corporation PLC Reports First Quarter 2013 Financial Results and Provides Update on Operations

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEDMINSTER, N.J., and DUBLIN, Ireland, May 9, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company focused on the commercialization and development of therapeutics...

Karolinska Development AB (publ) - Interim Report January - March 2013

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Karolinska Development AB (publ) (STO:KDEV) announces publication of its Interim report January-March, 2013. A conference call will be held today at 14.00 CET. Participant access...

Medicago, Inc. Announces 2013 First Quarter Financial Results

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

QUEBEC CITY, May 9, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biopharmaceutical company...

Neuland Labs Reports Financial Results For Fiscal Year 2013

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HYDERABAD, India, May 10, 2013 /PRNewswire/ -- Neuland Laboratories Ltd., (NSE: NEULANDLAB; BOM: 524558) a pharmaceutical...

Warner Chilcott, PLC Reports Operating Results for the Quarter Ended March 31, 2013

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, Ireland, May 10, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter ended March 31, 2013.

Help employers find you! Check out all the

Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORONTO , May 8, 2013 /CNW/ - Bioniche Life Sciences Inc. (BNC.TO) (BNC.AX), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the third quarter of...

China Biologic Products Reports Financial Results for the First Quarter of 2013

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEIJING, May 2, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today...

Medgenics, Inc. Reports First Quarter 2013 Financial Results

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the Company), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue...

Oncolytics Biotech Inc. Announces First Quarter 2013 Results

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CALGARY, May 9, 2013 /PRNewswire/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced its financial results and operational highlights for the quarter ended March...

Recordati S.p.A: Significant Sales and Earnings Growth in the First Quarter 2013

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MILAN, ITALY--(Marketwired - May 09, 2013) -

RECORDATI: SIGNIFICANT SALES AND EARNINGS GROWTH IN THE FIRST QUARTER2013(SALES 11.4%, NET INCOME 11.8%) THANKS TO...

Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NANJING, China, May 9, 2013 NANJING, China, May 9, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development...

Skyepharma PLC ??? Interim Management Statement

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LONDON, UK, 9 May, 2013 Ahead of its Annual General Meeting later today, Skyepharma PLC (LSE: SKP) publishes its Interim Management Statement for the period 1 January 2013 to 8 May 2013 and provides an update...

Takeda Pharmaceutical Co. Ltd. Announces Financial Results for the Fiscal Year Ended March 31, 2013 and Forecasts for the Fiscal Year Ending March 31, 2014

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

OSAKA, Japan, May 9, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda", "the Company") announced today...

AEterna Zentaris Reports First Quarter 2013 Financial and Operating Results

Wed, 08 May 2013 12:00:00 AM GMT

All amounts are in U.S. dollars (unless otherwise noted)

QUEBEC CITY, May 7, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a latestage drug development company specializing in oncology and endocrinology, today reported financial and operating results as at and for the first...

Epigenomics AG Announces Q1 2013 Financial Results and Reports on Operational Highlights

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Berlin, Germany, and, U.S.A., May 8, 2013 - Epigenomics AG (Frankfurt Prime Standard: ECX), the German-American cancer molecular diagnostics company, today announced its financial results for the first quarter...

Jazz Pharmaceuticals plc Announces First Quarter 2013 Financial Results

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, May 7, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced financial results for the first quarter ended March 31, 2013, updated 2013 financial guidance and key additions to its board...

Transition Therapeutics Inc. Announces Third Quarter Fiscal 2013 Financial Results

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORONTO , May 7, 2013 /CNW/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a product-focused biopharmaceutical company developing therapeutics for disease indications...

Aerocrine: Interim Report January - March 2013

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Aerocrine (STO:AERO-B) secures long-term financing. US clinical sales grew by 45%.

January March 2013

Global Net sales decreased by 14% to SEK 33.7m ...

Algeta Schedules First Quarter 2013 Results Presentation, Webcast and Conference Call

Tue, 07 May 2013 12:00:00 AM GMT

OSLO, NORWAY--(Marketwired - May 07, 2013) - Algeta ASA (OSE: ALGETA), a company focused onthedevelopment of novel targeted cancer therapeutics, will announce its firstquarter 2013 results on Wednesday, 15 May 2013. A presentation by Algeta'ssenior management team to investors, analysts and the press will take placeinOslo at 10:00 CET.

The presentation...

Evotec AG to Report First Quarter Results on 14 May 2013

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAMBURG, Germany, May 7, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for the first quarter of 2013 on Tuesday, 14 May 2013.

Help...

Flamel Technologies Announces First Quarter 2013 Results

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LYON, FRANCE--(Marketwired - May 07, 2013) - Flamel Technologies (NASDAQ: FLML) today announced its financial...

Karo Bio AB Release: INTERIM REPORT JANUARY-MARCH 2013

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

The JanuaryMarch period 2013 in brief

Net sales amounted to MSEK 8.1 (8.3)

Net loss for the group was MSEK 10.7 (54.0)

Help employers find...

MEDA Release: Interim Report, January???March 2013

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

MEDA AB (STO:MEDAA)

First quarter

Group net sales reached SEK 3,199 million (3,375) corresponding to unchanged organic growth[1] compared to previous year...

China Pharma Holdings, Inc. to Hold First Quarter of Fiscal Year 2013 Earnings Conference Call on Wednesday, May 15, 2013 at 8:30 a.m. ET

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAIKOU CITY, China, May 6, 2013 /PRNewswire/ -- China Pharma Holdings, Inc. ("China...

Transition Therapeutics Inc. to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. EST

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORONTO, May 6, 2013 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company...

Tianyin Pharmaceutical Co, Inc. to Host Third Quarter Fiscal Year 2013 Earnings Conference Call on Wednesday, May 15, 2013 at 9 a.m. ET

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CHENGDU, China, May 5, 2013 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company...

MorphoSys AG Reports Results for the First Quarter of 2013

Fri, 03 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MARTINSRIED, GERMANY and MUNCHEN, GERMANY--(Marketwired - May 03, 2013) -

MorphoSys AG / MorphoSys AG Reports Results for the First Quarter of 2013

Processed...

Nuvo Research Inc. Announces 2013 First Quarter Results

Thu, 02 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MISSISSAUGA, ON, May 1, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development...

Shire plc Release: New Chief Executive Reports Q1 Results and Sets out Strategy for Growth

Thu, 02 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, May 2, 2013 /PRNewswire/ --

Shire delivers 10% increase in Non GAAP earnings; full year EPS guidance in line with consensus(1)

Shire (LSE: SHP, NASDAQ: SHPG) announces results for...

Teva Pharmaceutical Industries Limited Reports First Quarter 2013 Results

Thu, 02 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended March 31, 2013.

During the quarter, we were pleased by the overall performance of our specialty products...

Valeant Pharmaceuticals International Reports 2013 First Quarter Financial Results

Thu, 02 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAVAL, Quebec, May 2, 2013 /PRNewswire/ --

2013 First Quarter Total Revenue $1.068 billion; an increase of 25% over the prior year

2013 First Quarter Product Sales $1.039 billion; an...

AEterna Zentaris to Announce First Quarter 2013 Financial and Operating Results on May 7, 2013 and Hold Annual Shareholders Meeting on May 8, 2013

Wed, 01 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

QUEBEC CITY, May 1, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce...

IMRIS to Hold First Quarter 2013 Results Conference Call and 2013 Annual Meeting of Shareholders

Wed, 01 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WINNIPEG, April 30, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)

Novo Nordisk A/S Increased Operating Profit by 18 Pct in the First Quarter of 2013

Wed, 01 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BAGSVAERD, DENMARK--(Marketwired - May 01, 2013) - Financial report for the period 1January 2013 to 31 March 2013.Sales growth of 13% driven by Victoza®, NovoRapid...

BioLineRx Ltd. to Report First Quarter 2013 Results on May 7, 2013

Tue, 30 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it will release its unaudited financial results for the quarter ended March 31, 2013 on Tuesday, May...

Dr. Reddy's Laboratories Ltd. to Release Q4 and Full Year FY13 Results on May 14, 2013

Tue, 30 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Fourth Quarter and Full year ended March 31, 2013 on Tuesday, May 14, 2013 after the Board Meeting. The results will be available on the Company...

PuriCore: Final Results for the Year Ended 31 December 2012

Tue, 30 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

30 April 2013 -- PuriCore (LSE: PURI), the water-based clean technology company, today announces its Final Results for the year ended 31 December 2012.

2012 Financial Highlights

...

QIAGEN N.V. Reports First Quarter 2013 Results

Tue, 30 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced results of operations for the first quarter of 2013, delivering innovation and growth in a challenging business environment.

"Our...

Sorin Group S.p.A. Announces Results for the First Quarter of 2013

Mon, 29 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

At a meeting held today and chaired by Rosario Bifulco, the Sorin S.p.A. (MIL:SRN) Board of Directors approved the results for the first quarter of 2013.

We are satisfied with the first quarter...

Adocia Announces Its Q1 2013 Revenues

Fri, 26 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Lyon, France, April 24, 2013 - Adocia (NYSE Euronext Paris: FR0011184241 - ADOC), a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins...

BioGaia AB Interim Report 1 January ??? 31 March 2013

Fri, 26 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Presidents comment: The year is off to a positive start with a growth rate of 25% (excludingforeign exchange effects) of our finished consumer products and in light of ourfocused efforts to enter the...

MorphoSys AG to Host Q1 2013 Conference Call on May 3, 2013

Fri, 26 Apr 2013 12:00:00 AM GMT

MARTINSRIED, GERMANY and MUNCHEN, GERMANY--(Marketwired - April 26, 2013) -

MorphoSys AG / MorphoSys to Host Q1 2013 Conference Call on May 3, 2013.

Processed and transmitted by Thomson Reuters ONE.

The issuer is solely responsible for the content of this announcement.

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish itsfirst...

Orexo AB: Interim Report, January-March 2013

Fri, 26 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Orexo (STO:ORX)

Unless otherwise stated in this report, all data refers to the Group. Figures in parentheses relate to the corresponding period in 2012.

The...

Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013

Fri, 26 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NANJING, China, April 26, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group (NYSE...

Swedish Orphan Biovitrum Publishes Report for the First Quarter 2013

Fri, 26 Apr 2013 12:00:00 AM GMT

April 26, 2013 -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its results for thefirst quarter 2013. Revenues for the quarter totalled MSEK 528.5 (506.7), withcontinued momentum across the commercial portfolio and several significantadvances in the pipeline.

Active Biotech AB Interim Report January - March 2013

Thu, 25 Apr 2013 12:00:00 AM GMT

LUND, SWEDEN--(Marketwired - April 25, 2013) -

Laquinimod

· first patient enrolled in CONCERTO, the third Phase IIIplacebo-controlledstudy for the treatment ofrelapsing-remitting multiple sclerosis

· data presented at AAN showed reduced disability progression formultiplesclerosis patients who commencedearly treatment with laquinimod...

Allenex AB: Interim Report January- March 2013

Thu, 25 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Press release, April 25, 2013

Allenex AB (STO:ALNX):

Net sales for the quarter amounted to SEK 26.8 million (30.0). Sales were impacted by a negative currency effect of SEK 1.0 million...

BioInvent Interim Report 1 January ??? 31 March 2013

Thu, 25 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

BioInvent (STO:BINV):

Important events in the first quarter and after the end of the reporting period

Positive results were reported in the phase I study...

Compugen Ltd. Reports First Quarter 2013 Financial Results

Thu, 25 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Compugen Ltd. (NASDAQ: CGEN) today reported financial results for the first quarter ending March 31, 2013.

Anat Cohen-Dayag, Ph.D., President and CEO of Compugen, stated, During this past quarter...

Cytos Biotechnology AG Reports First Quarter 2013 Financial Results and Recent Development

Thu, 25 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ZURICH, April 25, 2013 /PRNewswire/ --

- Phase 2b clinical trial of CYT003 in allergic asthma on-going as planned

- Cytos' VLP platform is basis for a phase 1 clinical trial with...

Ipsen???s First Quarter 2013 Sales

Thu, 25 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Commenting on the first quarter 2013 performance, Marc de Garidel, Chairman and Chief Executive Officer of Ipsen said: Ipsen is off to a good start this year with a solid specialty...